Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Early to Moderate Vision Loss (Celeste)

Clinical trial NCT05176717 · TERMINATED

Trial details

NCT number: NCT05176717
Sponsor: Laboratoires Thea
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Retinitis Pigmentosa Usher Syndrome Type 2 Deaf Blind Retinal Disease Eye Diseases Eye Diseases, Hereditary Eye Disorders Congenital Vision Disorders

Start date: 2021-12-15
Primary completion: 2022-08-02
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.